Ann: AusCann to Accelerate Human Drug Development Program, page-11

First 11 Last

Share
Profile

Follow
Scott th Ratbag

47,694 Posts.

649

21/09/21

17:56

Post #: 56244840
Share

Originally posted by AusCannOfficial: ↑

For clarity, the engagement is to outsource initial desktop research to evaluate opportunities to accelerate human drug development, by leveraging the data and assets that AusCann has already generated to date, in specific therapeutic areas that AusCann has pre-determined.

The team that we have within AusCann are highly capable, having designed, managed and executed significant cannabinoid-based research to date, including multiple in-vitro/in-vivo toxicological studies, randomised placebo-controlled clinical trials, pharmacokinetic studies and various other research activities in both human and animal across Canada, Europe, U.S and Australia.

This work has led to the submission of the first Investigational New Animal Drug file with the FDA-CVM for our cannabinoid-based veterinary drug program in the U.S, and the submission of the first cannabinoid-based regulatory dossier with the APVMA for an Australian veterinary medicine containing cannabidiol.

Outsourcing the initial gap analysis to a highly specialised Clinical Research Organisation enables AusCann to quickly gather a broad cross-section of scientific and regulatory input from industry experts, while allowing the AusCann team to remain focused on our upcoming milestones, which are our priority.

Expand

thank you for your post ACO.....

but what has happened to Neuvis? we've had no news on this for over 6 months and Neuvis was supposed to be our entry into prescription-only medicinal cannabis.

AC8 Price at posting: 8.7¢ Sentiment: Hold Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

IMA

Issues emerging as Australian companies tackle critical minerals challenge

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

There are more pages in this discussion • 19 more messages in this thread...

First 11 Last

Add AC8 (ASX) to my watchlist

Ann: AusCann to Accelerate Human Drug Development Program, page-11

Top Stories

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Issues emerging as Australian companies tackle critical minerals challenge

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Cauldron Energy reports "excellent" uranium assays in latest drill run

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

Defence MOU for propulsion systems pushes Aurora Lab shares higher

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Featured News